Drug intelligence / Profile preview

Astracytron Fito

Development stage
Unknown
Lead developer
Astrapharm
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Astracytron Fito is a multi-ingredient dietary supplement developed and manufactured by the Ukrainian pharmaceutical company Astrapharm. It is formulated as a powder for oral solution in sachets, designed to support the immune system and promote the proper functioning of the upper respiratory tract, nasal cavity, and paranasal sinuses during cold and flu seasons. The supplement contains a combination of herbal extracts, including verbena extract (*Verbena officinalis*), black elderberry fruit extract (*Sambucus nigra*), mullein extract (*Verbascum thapsus*), ginger root extract (*Zingiber officinale*), and pelargonium root extract (*Pelargonium sidoides*), enriched with vitamin C (ascorbic acid) and menthol. These active ingredients work synergistically to provide anti-inflammatory, expectorant, mucolytic, antiviral, and antioxidant effects, helping to relieve nasal congestion, ease breathing, and reduce symptoms of intoxication.

Brand names
Astracytron Fito
Other names
Astracitron PhytoАстрацитрон Фіто

Beyond the preview

Go deeper on Astracytron Fito.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astracytron Fito.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call